Showing results (31-40 of 74) with videos related to
Sort By:
Pageof 8
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|August 11, 2019
Artificial intelligence in cardiovascular imaging: state of the art and implications for the imaging cardiologistK R Siegersma, T Leiner, D P Chew, et al.American Heart Journal|March 29, 2001
Effect of smoking status and abciximab use on outcome after percutaneous coronary revascularization: Pooled analysis from EPIC, EPILOG, and EPISTENTL Cho, D L Bhatt, K Wolski, et al.American Heart Journal|June 30, 2001
Clinical outcome of a cohort of patients eligible for therapeutic angiogenesis or transmyocardial revascularizationD Mukherjee, K Comella, D L Bhatt, et al.Journal of Thrombosis and Thrombolysis|June 15, 2001
Clinical application of procedural platelet monitoring during percutaneous coronary intervention among patients at increased bleeding riskD Mukherjee, D P Chew, M Robbins, et al.Journal of the American College of Cardiology|March 25, 2000
Abciximab reduces mortality in diabetics following percutaneous coronary interventionD L Bhatt, S P Marso, A M Lincoff, et al.Journal of Thrombosis and Haemostasis : JTH|August 1, 2012
Safety and efficacy of protease-activated receptor-1 antagonists in patients with coronary artery disease: a meta-analysis of randomized clinical trialsD Capodanno, D L Bhatt, S Goto, et al.Heart (British Cardiac Society)|June 10, 2010
Six-month survival benefits associated with clinical guideline recommendations in acute coronary syndromesD P Chew, F A Anderson, A Avezum, et al.Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|October 17, 2009
In Germany diabetic patients with coronary artery disease are treated more intensively than diabetic patients with other manifestations of atherothrombosis--results from the REACH registryK G Parhofer, U Zeymer, R G Stark, et al.American Heart Journal|September 29, 1999
Corrected TIMI frame count does not predict 30-day adverse outcomes after reperfusion therapy for acute myocardial infarctionD L Bhatt, S G Ellis, T B Ivanc, et al.Thrombosis and Haemostasis|October 10, 2014
The optimal management of patients on oral anticoagulation undergoing coronary artery stenting. The 10th Anniversary OverviewA Rubboli, D P Faxon, K E Juhani Airaksinen, et al.Pageof 8